vs

Side-by-side financial comparison of ARDELYX, INC. (ARDX) and BLACKBERRY Ltd (BB). Click either name above to swap in a different company.

BLACKBERRY Ltd is the larger business by last-quarter revenue ($141.8M vs $94.5M, roughly 1.5× ARDELYX, INC.). BLACKBERRY Ltd runs the higher net margin — 9.7% vs -39.8%, a 49.5% gap on every dollar of revenue. On growth, ARDELYX, INC. posted the faster year-over-year revenue change (27.5% vs -0.8%). Over the past eight quarters, BLACKBERRY Ltd's revenue compounded faster (17.8% CAGR vs 13.6%).

Ardelyx, Inc. is a commercial-stage biopharmaceutical firm developing and commercializing innovative therapies for gastrointestinal, cardiorenal and metabolic diseases with high unmet medical needs. Its lead product is approved in the US for irritable bowel syndrome with constipation, and it holds a robust pipeline of early and late-stage drug candidates.

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

ARDX vs BB — Head-to-Head

Bigger by revenue
BB
BB
1.5× larger
BB
$141.8M
$94.5M
ARDX
Growing faster (revenue YoY)
ARDX
ARDX
+28.3% gap
ARDX
27.5%
-0.8%
BB
Higher net margin
BB
BB
49.5% more per $
BB
9.7%
-39.8%
ARDX
Faster 2-yr revenue CAGR
BB
BB
Annualised
BB
17.8%
13.6%
ARDX

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ARDX
ARDX
BB
BB
Revenue
$94.5M
$141.8M
Net Profit
$-37.6M
$13.7M
Gross Margin
77.5%
Operating Margin
8.4%
Net Margin
-39.8%
9.7%
Revenue YoY
27.5%
-0.8%
Net Profit YoY
224.5%
EPS (diluted)
$-0.15
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARDX
ARDX
BB
BB
Q1 26
$94.5M
Q4 25
$125.2M
$141.8M
Q3 25
$110.3M
$129.6M
Q2 25
$97.7M
$121.7M
Q1 25
$74.1M
$141.7M
Q4 24
$116.1M
$143.6M
Q3 24
$98.2M
$126.2M
Q2 24
$73.2M
$123.4M
Net Profit
ARDX
ARDX
BB
BB
Q1 26
$-37.6M
Q4 25
$-407.0K
$13.7M
Q3 25
$-969.0K
$13.3M
Q2 25
$-19.1M
$1.9M
Q1 25
$-41.1M
$-7.4M
Q4 24
$4.6M
$-10.5M
Q3 24
$-809.0K
$-19.7M
Q2 24
$-16.5M
$-41.4M
Gross Margin
ARDX
ARDX
BB
BB
Q1 26
Q4 25
91.3%
77.5%
Q3 25
96.4%
74.5%
Q2 25
87.3%
74.2%
Q1 25
83.4%
73.5%
Q4 24
84.3%
78.1%
Q3 24
84.0%
70.2%
Q2 24
87.1%
72.9%
Operating Margin
ARDX
ARDX
BB
BB
Q1 26
Q4 25
4.1%
8.4%
Q3 25
4.2%
8.9%
Q2 25
-14.7%
1.6%
Q1 25
-49.0%
-5.6%
Q4 24
7.0%
13.6%
Q3 24
2.3%
1.7%
Q2 24
-18.6%
-10.5%
Net Margin
ARDX
ARDX
BB
BB
Q1 26
-39.8%
Q4 25
-0.3%
9.7%
Q3 25
-0.9%
10.3%
Q2 25
-19.5%
1.6%
Q1 25
-55.5%
-5.2%
Q4 24
4.0%
-7.3%
Q3 24
-0.8%
-15.6%
Q2 24
-22.5%
-33.5%
EPS (diluted)
ARDX
ARDX
BB
BB
Q1 26
$-0.15
Q4 25
$-0.01
$0.02
Q3 25
$0.00
$0.02
Q2 25
$-0.08
$0.00
Q1 25
$-0.17
$-0.01
Q4 24
$0.01
$-0.02
Q3 24
$0.00
$-0.03
Q2 24
$-0.07
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARDX
ARDX
BB
BB
Cash + ST InvestmentsLiquidity on hand
$238.1M
$304.2M
Total DebtLower is stronger
$203.5M
$196.2M
Stockholders' EquityBook value
$148.6M
$741.1M
Total Assets
$504.5M
$1.2B
Debt / EquityLower = less leverage
1.37×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARDX
ARDX
BB
BB
Q1 26
$238.1M
Q4 25
$68.0M
$304.2M
Q3 25
$42.7M
$290.5M
Q2 25
$90.0M
$306.6M
Q1 25
$30.8M
$337.8M
Q4 24
$64.9M
$220.0M
Q3 24
$47.4M
$211.0M
Q2 24
$41.9M
$229.0M
Total Debt
ARDX
ARDX
BB
BB
Q1 26
$203.5M
Q4 25
$202.8M
$196.2M
Q3 25
$202.1M
$195.9M
Q2 25
$201.4M
$195.6M
Q1 25
$151.3M
$195.3M
Q4 24
$150.9M
Q3 24
$100.7M
Q2 24
$100.2M
Stockholders' Equity
ARDX
ARDX
BB
BB
Q1 26
$148.6M
Q4 25
$166.9M
$741.1M
Q3 25
$154.3M
$725.1M
Q2 25
$139.5M
$725.1M
Q1 25
$145.7M
$719.9M
Q4 24
$173.3M
$725.2M
Q3 24
$158.3M
$732.1M
Q2 24
$147.0M
$742.6M
Total Assets
ARDX
ARDX
BB
BB
Q1 26
$504.5M
Q4 25
$501.6M
$1.2B
Q3 25
$486.2M
$1.2B
Q2 25
$466.8M
$1.2B
Q1 25
$410.2M
$1.3B
Q4 24
$435.8M
$1.3B
Q3 24
$367.9M
$1.3B
Q2 24
$343.5M
$1.3B
Debt / Equity
ARDX
ARDX
BB
BB
Q1 26
1.37×
Q4 25
1.21×
0.26×
Q3 25
1.31×
0.27×
Q2 25
1.44×
0.27×
Q1 25
1.04×
0.27×
Q4 24
0.87×
Q3 24
0.64×
Q2 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARDX
ARDX
BB
BB
Operating Cash FlowLast quarter
$18.3M
Free Cash FlowOCF − Capex
$17.4M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARDX
ARDX
BB
BB
Q1 26
Q4 25
$21.0M
$18.3M
Q3 25
$365.0K
$3.9M
Q2 25
$-25.3M
$-18.0M
Q1 25
$-38.5M
$41.6M
Q4 24
$9.8M
$6.0M
Q3 24
$501.0K
$-16.0M
Q2 24
$-19.4M
$-15.1M
Free Cash Flow
ARDX
ARDX
BB
BB
Q1 26
Q4 25
$20.6M
$17.4M
Q3 25
$209.0K
$3.1M
Q2 25
$-26.0M
$-18.9M
Q1 25
$-38.8M
$41.2M
Q4 24
$9.2M
$5.2M
Q3 24
$364.0K
$-16.5M
Q2 24
$-19.5M
$-16.5M
FCF Margin
ARDX
ARDX
BB
BB
Q1 26
Q4 25
16.4%
12.3%
Q3 25
0.2%
2.4%
Q2 25
-26.6%
-15.5%
Q1 25
-52.3%
29.1%
Q4 24
7.9%
3.6%
Q3 24
0.4%
-13.1%
Q2 24
-26.7%
-13.4%
Capex Intensity
ARDX
ARDX
BB
BB
Q1 26
Q4 25
0.3%
0.6%
Q3 25
0.1%
0.6%
Q2 25
0.7%
0.7%
Q1 25
0.4%
0.3%
Q4 24
0.5%
0.6%
Q3 24
0.1%
0.4%
Q2 24
0.2%
1.1%
Cash Conversion
ARDX
ARDX
BB
BB
Q1 26
Q4 25
1.34×
Q3 25
0.29×
Q2 25
-9.47×
Q1 25
Q4 24
2.11×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARDX
ARDX

IBSRELA$70.1M74%
XPHOZAH$23.3M25%
Non-cash royalty revenue related to the sale of future royalties$695.0K1%
Product supply revenue$354.0K0%

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

Related Comparisons